✦ LIBER ✦

PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

✍ Scribed by Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost analysis of glatiramer acetate vs.

✍ Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PNP15: COST-UTILITY ANALYSIS OF THE TREA

✍ C Rubio-Terrés; F Medina; I Aristegui; G Izquierdo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PND33 Cost Minimization Analysis of Fing

✍ B. Verheggen; M. Treur; M. Groot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND8: IMPLICATIONS OF PRESCRIBING FOR PA

✍ P Brambleby; UK Bose; S Stanley 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB